-
Alopecia: First ever treatment approved for NHS use marks ‘monumental day’ | UK News
admin
Thousands of patients could benefit from the first ever alopecia treatment approved for the NHS. Alopecia areata is an autoimmune disease, where the body’s immune system attacks the hair follicles and causes hair to fall out. Alopecia UK hailed the decision as a “monumental day” for people with the condition, with patients going “far too…
-
Injection that can ‘reduce risk’ of food allergy reactions approved for use in US | US News
admin
An injection that can “reduce the risk of harmful allergic reactions” in people with food allergies has been approved for use in the US. Certain adults and children aged one or over who have immunoglobulin E-mediated food allergies will be eligible to have the injection, the US Food and Drug Administration (FDA) said. The jab…
-
Mounjaro: New weight loss drug approved for use in Britain to be available ‘within weeks’ | UK News
admin
An American weight loss drug approved in a four-dose injection pen format for use in Britain could be available “within weeks”. Mounjaro, also known as tirzepatide, is a diabetes drug that was authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) to help obese and overweight adults lose and manage weight in November last…
-
Cheap malaria vaccine developed with help of Oxford scientists approved for global rollout | World News
admin
The World Health Organisation (WHO) has approved a low-cost, readily available vaccine for malaria that promises to help ease one of the greatest disease burdens on the developing world. The R21 vaccine, developed by the University of Oxford, the Serum Institute of India and drug maker Novavax, could help reduce the 500,000 malaria-associated deaths that…
-
New treatment approved for those with advanced womb cancer is ‘game changing’ | UK News
admin
A “game changing” new treatment has been approved for those diagnosed with advanced or recurrent endometrial cancer. As many as 700 people every year will benefit from the “landmark” approval of pembrolizumab (Keytruda), a type of cancer treatment called immunotherapy, and lenvatinib (Lenvima), a cancer growth blocker. The drugs work together to stimulate the body’s…
-
Microsoft-Activision Blizzard £55bn merger approved by EU – despite UK rejection | Science & Tech News
admin
The $68.7bn (£55bn) mega merger between Microsoft and game developer Activison Blizzard has been approved by the European Union, just weeks after it was blocked by the UK. European regulators said they accept commitments made by Microsoft that its offer to take over the developer behind Call Of Duty, would not lessen competition. In April,…